Results of a system of registration and follow-up of patients with hydatidiform mole.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000652:urine*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006828:Hydatidiform Mole / Q000652:urine*; D010051:Ovarian Neoplasms / Q000652:urine*; D011247:Pregnancy; D011379:Prognosis; D012042:Registries; D014328:Trophoblastic Neoplasms / Q000652:urine*
D000970:Antineoplastic Agents; D006063:Chorionic Gonadotropin